CVS HEALTH Corp
CVSNYSECIK 64803Consumer staplesFiscal year ends Dec 31
Reports and events: 372 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-02-0806:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-18-000012 |
| 2018-02-0617:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000064803-18-000007 |
| 2018-02-0117:20 ET | 8-K | 8.01 Other events | 0001193125-18-029474 |
| 2018-01-0407:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-002185 |
| 2017-12-1917:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-17-373753 |
| 2017-12-0517:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-17-361800 |
| 2017-12-0407:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-17-359526 |
| 2017-11-0616:50 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001558370-17-008250 |
| 2017-11-0606:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-17-000032 |
| 2017-08-0807:16 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001558370-17-006198 |
| 2017-08-0806:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-17-006194 |
| 2017-05-1216:45 ET | 8-K | 5.07 Shareholder vote results | 0001193125-17-168702 |
| 2017-05-0216:07 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001558370-17-003258 |
| 2017-05-0207:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-17-003216 |
| 2017-03-3116:16 ET | DEF 14A | Proxy statementPeriod 2017-05-10 | 0001206774-17-001033 |
| 2017-03-0217:01 ET | 8-K | 9.01 Financial statements and exhibits | 0000064803-17-000008 |
| 2017-02-0916:03 ET | 10-K | Annual reportPeriod 2016-12-31 | 0000064803-17-000006 |
| 2017-02-0906:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-17-000004 |
| 2016-12-1507:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000064803-16-000104 |
| 2016-11-0809:34 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-16-000099 |
| 2016-11-0807:00 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0000064803-16-000097 |
| 2016-11-0806:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-16-000096 |
| 2016-08-0216:41 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0000064803-16-000090 |
| 2016-08-0207:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-16-000088 |
| 2016-06-1416:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-621362 |
| 2016-06-0216:37 ET | 8-K | 8.01 Other events | 0000064803-16-000084 |
| 2016-05-3108:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-607314 |
| 2016-05-2517:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-602417 |
| 2016-05-2016:37 ET | 8-K | 5.07 Shareholder vote results | 0000064803-16-000082 |
| 2016-05-1816:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-594552 |
| 2016-05-1608:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-591252 |
| 2016-05-0316:48 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0000064803-16-000080 |
| 2016-05-0309:02 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-16-000078 |
| 2016-05-0306:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-16-000076 |
| 2016-04-0809:28 ET | DEF 14A | Proxy statementPeriod 2016-05-19 | 0001206774-16-005376 |
| 2016-02-0916:29 ET | 10-K | Annual reportPeriod 2015-12-31 | 0000064803-16-000074 |
| 2016-02-0906:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-16-000072 |
| 2016-01-2616:47 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000064803-16-000070 |
| 2015-12-1607:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-15-000066 |
| 2015-10-3016:50 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0000064803-15-000064 |
| 2015-10-3007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-15-000062 |
| 2015-10-1417:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-15-343838 |
| 2015-09-2216:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000064803-15-000060 |
| 2015-08-1816:46 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000064803-15-000058 |
| 2015-08-0517:36 ET | DEF 14A | Proxy statementPeriod 2015-08-04 | 0000064803-15-000056 |
| 2015-08-0416:54 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0000064803-15-000054 |
| 2015-08-0407:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000064803-15-000051 |
| 2015-07-2013:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-15-256793 |
| 2015-07-1716:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-15-256071 |
| 2015-06-1507:06 ET | 8-K | 7.01 Regulation FD disclosure | 0000064803-15-000036 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.